Search Result "SGLT2i."
The Role of SGLT2i in the Prevention and Treatment of Heart Failure
Ebook: Frontiers in Cardiovascular Drug Discovery
Volume: 5 Year: 2020
Author(s): Hasan AlTurki,Ahmed AlTurki,Mark Sherman,Abhinav Sharma,Thao Huynh
Doi: 10.2174/9789811413247120050004
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1522-1532
Author(s): Niki Katsiki,Dimitri P. Mikhailidis,Michael J. Theodorakis
GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Journal: Current Hypertension Reviews
Volume: 17 Issue: 2 Year: 2021 Page: 149-158
Author(s): Aschner Pablo,Blanc Evelyn,Folino Claudia,Morosán A. Yanina
Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i
Journal: Current Vascular Pharmacology
Volume: 19 Issue: 2 Year: 2021 Page: 233-240
Author(s): Olga Lamacchia,Maria Rosaria Sorrentino
Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors inChronic Kidney Disease
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 21 Year: 2023 Page: 1659-1670
Author(s):
Pharmacological Treatment of Heart Failure: Recent Advances
Journal: Current Cardiology Reviews
Volume: 20 Issue: 2 Year: 2024 Page: 29-38
Author(s): Jonathan C.H. Chan
Effect of SGLT2 Inhibitors and Metformin on Inflammatory and PrognosticBiomarkers in Type 2 Diabetes Patients
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 4 Year: 2023 Page: 530-547
Author(s):
Cardiorenal Protections of SGLT2 Inhibitors in the Treatment of Type 2Diabetes
Journal: Current Diabetes Reviews
Volume: 19 Issue: 8 Year: 2023 Page: 46-61
Author(s):
Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use
Journal: Current Drug Safety
Volume: 16 Issue: 1 Year: 2021 Page: 73-81
Author(s): Henrik V.B. Laursen,Johan B. Røikjer,Jakob Dal,Morten Hasselstrøm Jensen
Cellular and Mitochondrial Pathways Contribute to SGLT2Inhibitors-mediated Tissue Protection: Experimental and Clinical Data
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 13 Year: 2024 Page: 969-974
Author(s): Sebastián GarcÃa Menéndez